- Home
- ARCB vs TVTX Comparison
ARCB vs TVTX Comparison
Compare ARCB & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCB
- TVTX
- Stock Information
- Founded
- ARCB 1923
- TVTX 2008
- Country
- ARCB United States
- TVTX United States
- Employees
- ARCB N/A
- TVTX N/A
- Industry
- ARCB Trucking Freight/Courier Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ARCB Industrials
- TVTX Health Care
- Exchange
- ARCB Nasdaq
- TVTX Nasdaq
- Market Cap
- ARCB 1.6B
- TVTX 1.5B
- IPO Year
- ARCB N/A
- TVTX N/A
- Fundamental
- Price
- ARCB $71.98
- TVTX $24.64
- Analyst Decision
- ARCB Buy
- TVTX Strong Buy
- Analyst Count
- ARCB 13
- TVTX 16
- Target Price
- ARCB $93.25
- TVTX $35.20
- AVG Volume (30 Days)
- ARCB 340.8K
- TVTX 2.7M
- Earning Date
- ARCB 11-05-2025
- TVTX 10-30-2025
- Dividend Yield
- ARCB 0.67%
- TVTX N/A
- EPS Growth
- ARCB 27.88
- TVTX N/A
- EPS
- ARCB 6.77
- TVTX N/A
- Revenue
- ARCB $4,054,102,000.00
- TVTX $333,865,000.00
- Revenue This Year
- ARCB N/A
- TVTX $83.87
- Revenue Next Year
- ARCB $5.06
- TVTX $40.99
- P/E Ratio
- ARCB $10.63
- TVTX N/A
- Revenue Growth
- ARCB N/A
- TVTX 87.94
- 52 Week Low
- ARCB $55.19
- TVTX $12.91
- 52 Week High
- ARCB $123.26
- TVTX $28.69
- Technical
- Relative Strength Index (RSI)
- ARCB 52.41
- TVTX 59.38
- Support Level
- ARCB $66.88
- TVTX $23.22
- Resistance Level
- ARCB $70.65
- TVTX $25.10
- Average True Range (ATR)
- ARCB 2.54
- TVTX 1.27
- MACD
- ARCB 0.21
- TVTX -0.23
- Stochastic Oscillator
- ARCB 64.15
- TVTX 63.75
About ARCB ArcBest Corporation
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.